CEFPROZIL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Cefprozil, and when can generic versions of Cefprozil launch?
Cefprozil is a drug marketed by Apotex Inc, Aurobindo Pharma, Chartwell Rx, Lupin, Orchid Hlthcare, Ranbaxy Labs Ltd, Sandoz, Alkem Labs Ltd, Teva, and Wockhardt. and is included in sixteen NDAs.
The generic ingredient in CEFPROZIL is cefprozil. There are thirteen drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the cefprozil profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Cefprozil
A generic version of CEFPROZIL was approved as cefprozil by CHARTWELL RX on November 14th, 2005.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CEFPROZIL?
- What are the global sales for CEFPROZIL?
- What is Average Wholesale Price for CEFPROZIL?
Summary for CEFPROZIL
| US Patents: | 0 |
| Applicants: | 10 |
| NDAs: | 16 |
| Finished Product Suppliers / Packagers: | 7 |
| Raw Ingredient (Bulk) Api Vendors: | 55 |
| Clinical Trials: | 14 |
| Patent Applications: | 6,191 |
| Drug Prices: | Drug price information for CEFPROZIL |
| DailyMed Link: | CEFPROZIL at DailyMed |
Recent Clinical Trials for CEFPROZIL
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| The Affiliated Hospital of Qingdao University | Phase 1 |
| Julio Ramirez | Early Phase 1 |
| University of Louisville | Early Phase 1 |
Anatomical Therapeutic Chemical (ATC) Classes for CEFPROZIL
US Patents and Regulatory Information for CEFPROZIL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Wockhardt | CEFPROZIL | cefprozil | TABLET;ORAL | 065428-002 | Jun 14, 2007 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Ranbaxy Labs Ltd | CEFPROZIL | cefprozil | TABLET;ORAL | 065198-002 | Dec 13, 2006 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Teva | CEFPROZIL | cefprozil | TABLET;ORAL | 065208-001 | Dec 6, 2005 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Apotex Inc | CEFPROZIL | cefprozil | FOR SUSPENSION;ORAL | 065351-001 | Feb 29, 2012 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
